Hygeia Healthcare Holdings Co., Limited repurchased 256,400 ordinary shares on 28 April 2026 through The Stock Exchange of Hong Kong at prices between HKD 11.68 and HKD 11.72, translating to a volume-weighted average of HKD 11.695 per share and a total outlay of HKD 2.99 million.

Following the transaction, the number of issued shares outstanding (excluding treasury shares) fell by 0.04% to 613.78 million, while treasury stock rose to 4.72 million shares. Total issued capital remained unchanged at 618.50 million shares.

The buyback was executed under a mandate granted on 27 June 2025 that permits the repurchase of up to 61.85 million shares. Cumulative purchases under this authority now stand at 4.72 million shares, equivalent to 0.76% of the company’s issued share count on the mandate date.

In accordance with Hong Kong listing rules, Hygeia Healthcare is subject to a 30-day moratorium on new share issues or sales of treasury shares, effective until 28 May 2026.